In Depth 30 May 2024 Covalent biologics: a new class of drugs on the horizon The field of covalent biologics has made headway recently, as the only biotech in the space has bagged $100 million to move its pipeline to the clinic. May 30, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Podcast 24 May 2024How biotech is tackling myasthenia gravis To talk about the disease, how it is being treated, and what is in the pipeline for future treatments, we had a conversation with Dana Vigier, head of Central Eastern and Northern Europe at Alexion. May 24, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Expert Advice 26 Apr 2024 Biotech career: What it’s really like being a research assistant Labiotech spoke to Elina Kuznecova, a research assistant at the University of Oxford, to find out about what the role of a research assistant entails. April 26, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 22 Mar 2024 6 biotechnology universities in the UK leading the way for future talent Discover the pinnacle of biotechnology education in the UK with our article to the top universities offering cutting-edge programs. March 22, 2024 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 8 Mar 2024 Eight biotechnology universities in Germany cultivating future leaders Explore Germany’s top biotechnology universities! Uncover where tomorrow’s leaders are trained, bridging science with market success. March 8, 2024 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 26 Jan 2024 Long COVID: are we on the verge of a breakthrough? Studies and recent developments in long COVID research could pave the way for more diagnostic and therapeutic opportunities. January 26, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 12 Jan 2024 AI and a brain organoid: can this combo take on supercomputers? Explore the groundbreaking fusion of brain organoids and AI in the creation of Brainoware, the world’s first biohybrid computer. January 12, 2024 - 5 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 11 Jan 2024 Ten NK cell therapy companies to look out for this year As biotechs raise funding to advance their NK cell therapy candidates in the clinic, here are ten companies in the space to watch out for. January 11, 2024 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Weekly Roundup 15 Dec 2023 Pharvaris’ $300 million public offering; Genentech’s breast cancer trial success; new neuromuscular disease target discovered What’s been going on in the world of biotech of late? Find out with Labiotech’s weekly roundup of the latest biotech news. December 15, 2023 - 14 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Weekly Roundup 8 Dec 2023 Xenon’s $345 million public offering; EyePoint Pharmaceuticals’ trial success; gene therapy found to reduce liver cancer What’s been going on in the world of biotech of late? Find out with Labiotech’s weekly roundup of the latest biotech news. December 8, 2023 - 14 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 1 Dec 2023 Arvinas raises $350 million; Exonate’s trial reaps success; new cancer drugs discovered Here is Labiotech’s weekly roundup of the latest biotech news. Stay in the loop by subscribing to our newsletter for direct updates to your inbox. The latest biotech news in fundraising In the news this week, biotech Arvinas raises $350 million PIPE American protein degradation company Arvinas has bagged $350 million in a private placement (PIPE). The […] December 1, 2023 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Weekly Roundup 24 Nov 2023 Viva’s $210 million round; Merck grabs Caraway for $610 million; Genentech signs a deal with NVIDIA Here is Labiotech’s weekly roundup of the latest biotech news. Whether it is partnerships, clinical trials, or fundraising, we have got you covered. Stay in the loop by subscribing to our newsletter for direct updates to your inbox. Viva Biotech closes $210 million funding round Chinese company Viva Biotech closed a funding round worth $210 […] November 24, 2023 - 14 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email